Elevance Health, Inc. $ELV Shares Bought by Whittier Trust Co.

Whittier Trust Co. raised its holdings in Elevance Health, Inc. (NYSE:ELV) by 6.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 91,957 shares of the company’s stock after acquiring an additional 5,345 shares during the period. Whittier Trust Co.’s holdings in Elevance Health were worth $35,766,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Liberty One Investment Management LLC raised its holdings in Elevance Health by 20.0% in the 2nd quarter. Liberty One Investment Management LLC now owns 12,794 shares of the company’s stock valued at $4,976,000 after acquiring an additional 2,133 shares during the last quarter. Avidian Wealth Enterprises LLC grew its stake in shares of Elevance Health by 16.5% in the 2nd quarter. Avidian Wealth Enterprises LLC now owns 693 shares of the company’s stock valued at $270,000 after buying an additional 98 shares during the period. WESPAC Advisors SoCal LLC grew its stake in shares of Elevance Health by 10.8% in the 2nd quarter. WESPAC Advisors SoCal LLC now owns 4,244 shares of the company’s stock valued at $1,651,000 after buying an additional 412 shares during the period. Stephens Inc. AR grew its stake in shares of Elevance Health by 0.9% in the 2nd quarter. Stephens Inc. AR now owns 9,599 shares of the company’s stock valued at $3,734,000 after buying an additional 87 shares during the period. Finally, Beverly Hills Private Wealth LLC grew its stake in shares of Elevance Health by 7.3% in the 2nd quarter. Beverly Hills Private Wealth LLC now owns 14,546 shares of the company’s stock valued at $5,658,000 after buying an additional 994 shares during the period. Institutional investors and hedge funds own 89.24% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Sanford C. Bernstein dropped their price target on shares of Elevance Health from $445.00 to $420.00 and set an “outperform” rating for the company in a research note on Thursday, October 16th. Leerink Partnrs cut shares of Elevance Health from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Argus reissued a “hold” rating on shares of Elevance Health in a research note on Monday, July 21st. Morgan Stanley increased their price target on shares of Elevance Health from $316.00 to $359.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 14th. Finally, Leerink Partners reissued a “market perform” rating and issued a $310.00 price target (down previously from $510.00) on shares of Elevance Health in a research note on Friday, July 18th. Ten equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $400.06.

Insider Buying and Selling at Elevance Health

In other Elevance Health news, Director Susan D. Devore bought 1,200 shares of Elevance Health stock in a transaction on Tuesday, August 19th. The shares were bought at an average cost of $312.15 per share, for a total transaction of $374,580.00. Following the acquisition, the director directly owned 3,502 shares in the company, valued at $1,093,149.30. This represents a 52.13% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.29% of the company’s stock.

Elevance Health Stock Performance

NYSE:ELV opened at $354.33 on Tuesday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.44 and a current ratio of 1.44. The stock has a market capitalization of $79.79 billion, a P/E ratio of 15.08, a PEG ratio of 1.27 and a beta of 0.59. The company has a 50 day moving average price of $323.21 and a 200 day moving average price of $354.62. Elevance Health, Inc. has a fifty-two week low of $273.71 and a fifty-two week high of $458.75.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.